Board of Directors

Our Board of Directors is a group of volunteers committed to FBC’s mission to find treatments and cures for blinding eye diseases. The Board includes representatives from the corporate and medical worlds, as well as individuals affected by vision loss.

Executive Committee & Officers

Andrew Burke, Chair Partner, Steward McKelvey Halifax, Nova Scotia

Tara James, Vice Chair Senior Counsel, BMO Financial Group Toronto, Ontario

George Sheen, Treasurer  Partner, PwC (retired) Toronto, Ontario

Stephen Aylward, Corporate Secretary Lawyer, Stockwoods LLP Toronto, Ontario

Robert F. Richards, Chair of the Audit Committee Chairman, Heathbridge Capital Management Ltd. Toronto, Ontario

Malcolm Hunter, Executive Officer President, Fred Deeley Limited Vancouver, British Columbia

Directors

Alan Richard Berger, BSc, MDCM, FRCSC, Dip. ABO, Assistant Professor of Ophthalmology, Vitreoretinal Surgeon, St. Michael’s Hospital, Vice Chairman, University of Toronto, Department of Ophthalmology Vision Sciences

Michel Cayouette, PhD Research Unit Director, Institut de recherche cliniques de Montreal (IRCM) Research Associate Professor, University of Montreal Montreal, Quebec

Netan Choudhry, MD, FRCS(C), DABO, Co-founder and Medical Director at Vitreous Retina Macular Specialists of Toronto

David Drury Managing Director, IBM Canada Ltd. Toronto, Ontario

Selena Friesen, OD, Optometrist, Waverley Eye Care

Donald F. Reed President and CEO, Franklin Templeton Investments Corp. (retired) Toronto, Ontario

Mike Seed, CIM First Vice President & Portfolio Manager, Seed Financial Group, CIBC Wood Gundy Edmonton, Alberta

Tahir Shafiq, Independent Management Consultant

Rob Simmons Vice President, Finance & Business Affairs, Atomic Cartoons Vancouver, British Columbia

Deepa Yoganathan, MD, FRCSC, DABO, Ophthalmologist, Assistant Professor in the Department of Ophthalmology and Vision Sciences, University of Toronto